logo
  

Kaiser Aluminum Turns To Loss In Q3

California-based mining company Kaiser Aluminum Corporation (KALU) turned to loss in the third quarter.

Net loss reported by Kaiser Aluminum was $2 million or $0.14 loss per share, compared to a profit of $0.4 million or $0.02 earnings per share last year.

Excluding one-time items, the income was $9 million or $0.57 earnings per share, up from $6 million or $0.39 earnings per share. On average, four analysts polled by Thomson Reuters estimated the earnings to be $1.32 per share for the quarter.

Kaiser revenue for the quarter was $751 million, up from $256 million last year.

The results were offset by a loss of $445 million in the less hedged cost of alloy metals segment from $101 million last year. The Street view for the revenue was $782.86 million.

Kaiser expects the value-added revenue for the next quarter to go up by a low single-digit while labor cost and supply chain disruptions prevail.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
Follow RTT